USANA Health Sciences (NYSE:USNA) Reaches New 1-Year Low - What's Next?

USANA Health Sciences, Inc. (NYSE:USNA - Get Free Report)'s share price reached a new 52-week low during trading on Tuesday . The company traded as low as $34.59 and last traded at $34.86, with a volume of 11798 shares changing hands. The stock had previously closed at $35.05.

Analysts Set New Price Targets

A number of equities analysts have recently weighed in on the stock. DA Davidson lowered their price target on shares of USANA Health Sciences from $46.00 to $38.00 and set a "neutral" rating on the stock in a research note on Thursday, July 25th. StockNews.com downgraded shares of USANA Health Sciences from a "strong-buy" rating to a "buy" rating in a research report on Wednesday, July 24th.

USANA Health Sciences Trading Down 1.6 %

The firm has a 50 day moving average price of $38.02 and a 200-day moving average price of $42.59. The firm has a market cap of $657.26 million, a price-to-earnings ratio of 10.75, a P/E/G ratio of 1.20 and a beta of 0.89.

USANA Health Sciences (NYSE:USNA - Get Free Report) last announced its quarterly earnings results on Tuesday, July 23rd. The company reported $0.54 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.65 by ($0.11). USANA Health Sciences had a net margin of 6.29% and a return on equity of 11.13%. The business had revenue of $212.87 million during the quarter, compared to analysts' expectations of $218.64 million. During the same period last year, the company earned $0.89 EPS. As a group, equities analysts expect that USANA Health Sciences, Inc. will post 2.5 earnings per share for the current fiscal year.

Insider Activity at USANA Health Sciences

In other USANA Health Sciences news, insider Paul A. Jones sold 6,266 shares of the stock in a transaction on Tuesday, August 13th. The stock was sold at an average price of $38.38, for a total transaction of $240,489.08. The sale was disclosed in a document filed with the SEC, which is available at this link. In other news, insider Paul A. Jones sold 6,266 shares of the business's stock in a transaction on Tuesday, August 13th. The shares were sold at an average price of $38.38, for a total transaction of $240,489.08. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Gilbert A. Fuller sold 674 shares of the stock in a transaction on Wednesday, August 7th. The stock was sold at an average price of $39.69, for a total value of $26,751.06. The disclosure for this sale can be found here. In the last quarter, insiders sold 7,940 shares of company stock valued at $311,670. 0.33% of the stock is owned by insiders.

Institutional Trading of USANA Health Sciences

A number of institutional investors and hedge funds have recently bought and sold shares of the business. CWM LLC raised its position in USANA Health Sciences by 21.8% in the first quarter. CWM LLC now owns 1,543 shares of the company's stock valued at $75,000 after purchasing an additional 276 shares during the period. Exchange Traded Concepts LLC raised its holdings in shares of USANA Health Sciences by 4.4% during the 3rd quarter. Exchange Traded Concepts LLC now owns 7,709 shares of the company's stock valued at $292,000 after buying an additional 322 shares during the period. Price T Rowe Associates Inc. MD lifted its position in USANA Health Sciences by 9.2% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 5,849 shares of the company's stock worth $284,000 after acquiring an additional 494 shares in the last quarter. Public Sector Pension Investment Board boosted its holdings in USANA Health Sciences by 5.4% in the 2nd quarter. Public Sector Pension Investment Board now owns 24,270 shares of the company's stock worth $1,098,000 after acquiring an additional 1,242 shares during the period. Finally, State Board of Administration of Florida Retirement System grew its position in USANA Health Sciences by 22.7% in the first quarter. State Board of Administration of Florida Retirement System now owns 8,430 shares of the company's stock valued at $409,000 after acquiring an additional 1,560 shares in the last quarter. Institutional investors and hedge funds own 54.25% of the company's stock.

USANA Health Sciences Company Profile

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.